Both in Pharmaceuticals
Grace Therapeutics vs Biote
Over the past year GRCE returned −41.4% and BTMD returned −57.0%; their daily moves had a correlation of 0.06.
GRCE −41.4% BTMD −57.0%Growth of $1, one year, split-adjusted
| Metric | GRCE | BTMD |
|---|---|---|
| Price | $1.81 | $1.23 |
| Market cap | $38.1M | $35.3M |
| Today | −1.63% | +9.82% |
| 1 month | −12.3% | +7.9% |
| 6 months | −23.6% | −44.1% |
| Year to date | −47.7% | −52.7% |
| 1 year | −41.8% | −56.5% |
| Revenue growth (YoY) | — | −9.5% |
| Gross margin | — | 65.4% |
| Net margin | — | −14.8% |
| P/E (TTM) | — | 6.0× |
| Price / sales | — | 0.2× |
| Net cash | $13.8M | -$110.3M |
| Dividend yield | — | — |
| Volatility (60d) | 43.8% | 69.6% |
| Short % of float | 11.2% | 5.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).